Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Sept 2026 for Tenax Therapeutics, INC., €9,451. Read the official filing
Filing timeline
BuySaleThomas R. Staab II
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Thomas R. Staab II: trading record in brief
Thomas R. Staab II, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in LENSAR, Inc., Biocryst Pharmaceuticals Inc and Tenax Therapeutics, Inc. The record holds 16 filings, for trades running from 1 January 2016 to 11 September 2026.
Purchases make up the whole of the open-market record (2 purchases, €16k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 10 share grants and 4 option exercises. Since January 2026: 1 purchase and no sales on the market.
On 15 September 2026 came the latest disclosure, an open-market purchase for €9,451 in Tenax Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas R. Staab II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
5,675 shares@ US$1.935Common StockSEC:0001193125-26-392319:0
Canonical exit: 10 Dec 2026 (T+90)
10,000 shares0Common StockSEC:0001193125-26-221926:0
5,500 shares@ US$2.6525.7% of flowCommon StockSEC:0001193125-26-116117:0
1,076 shares@ US$11.3213.2% of flowCommon StockSEC:0001193125-26-061464:0
1,826 shares@ US$11.5723.3% of flowCommon StockSEC:0001193125-26-011796:0
12,766 shares0Common StockSEC:0000950170-25-024336:0
1,839 shares@ US$8.2540.0% of flowCommon StockSEC:0000950170-25-015541:0
3,500 shares@ US$2.6523.1% of flowCommon StockSEC:0000950170-24-095487:0
1,853 shares@ US$4.4320.3% of flowCommon StockSEC:0000950170-24-055774:0
6,656 shares0Common StockSEC:0000899243-23-001798:0
2,025 shares@ US$3.16216.6% of flowCommon StockSEC:0000899243-22-037965:0
Canonical exit: 6 Mar 2023 (T+90)
15,000 shares0Common StockSEC:0000899243-22-001924:0
4,823 sharesCommon StockSEC:0001127602-16-037574:0
2,500 sharesCommon StockSEC:0001127602-16-037469:0
12,500 sharesCommon StockSEC:0001127602-16-037469:1
1,676 sharesCommon StockSEC:0001127602-16-035651:0
16 of 16 declarations
